Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-06-12

Clinical Trial Update: Prophylactic Use of Hydroxycobolamin in Vasoplegic Syndrome in Adult Patients Undergoing Cardiopulmonary Bypass [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update notes the completion of Phase 2 and Phase 3 studies evaluating prophylactic hydroxycobolamin for vasoplegic syndrome in adults underg…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydroxycobolamin (hydroxocobalamin)

Snippet

Sponsor: Ain Shams University | Conditions: Vasoplegic Syndrome | Phase 2, Phase 3 | Status: COMPLETED